Later this week, the FDA plans to approve, as the first outpatient COVID drugs, therapeutics that are extremely dangerous and unproven, even as the agency goes to war against cheap, safe, and proven drugs with a track record of no serious adverse events.
Newsweek review of financial filings in Congress has found that lawmakers who are driving legislation to protect Uyghurs in China are also invested—either directly in the form of stocks, or indirectly via mutual funds—in major companies tied to the oppression in Xinjiang.
The Pentagon, working together with the Anti-Defamation League, issued new rules on Monday to further suppress the First Amendment rights of American service members.
Gen. Michael Flynn has filed a complaint to stop a subpoena from the House Select Committee to Investigate the January 6th Attack on the United States Capitol. He also filed a motion for a temporary restraining order and preliminary injunction specifically against Speaker of the House Nancy Pelosi.
States with Republican governors and legislatures are leading Americans back to work quicker than those led by Democrats, according to an analysis of the state-by-state unemployment data from the Department of Labor.